Officer and Director Stock Transactions for Bicara Therapeutics Inc.

Ryan Cohlhepp, President and COO of Bicara Therapeutics Inc., reported several stock transactions on April 15, 2026. These transactions were executed under a Rule 10b5-1 trading plan. Cohlhepp acquired 8,000 shares of Common Stock at $3.7898 per share, increasing his post-transaction holdings to 208,641 shares. Subsequently, he disposed of 8,000 shares at a weighted average price of $23.0073, with individual sales ranging from $22.58 to $23.255, leaving him with 200,641 shares. An additional 4,500 shares were disposed of at the same weighted average price, resulting in 196,141 shares. In a related derivative transaction, Cohlhepp disposed of 8,000 stock options (right to buy) with a conversion price of $3.7898, leaving him with 109,334 options. The underlying securities for these options are Common Stock.